Alacris Theranostics enters agreement with GSK
To use ModCell System for early stage cancer research
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Omkar Speciality Chemicals: Thinking big
Omkar Speciality Chemicals is one of the fastest growing chemical companies in India. Sachin Jagdale reports about company's…
Violators of law… Drug Regulatory Authorities (DRAs)
As pharmaceutical majors from developed markets are expected to outsource huge amount of manufacturing to low cost destinations in…
EMA sets out next steps on access to clinical trial data
Invites expressions of interest for advisory groups
CARE Research releases pharma, CRAMS performance updates
CRO segment to rise but likely to get hit by global economic crisis in near term
DIA begins transition to new executive leadership
DIA will announce plans for the executive director search in January 2013
Manjiri Gharat elected to FIP CPS Executive Committee Member
Will contribute to community pharmacy development globally for a four year term from 2012-16
Strides, Eli Lily tie up to tap emerging markets
Agila Specialties to make, Eli Lilly to market branded generic cancer meds
Venus gets DCGI approval for phase III trial of cancer detection NCE
Venus is planning to launch this NCE by last quarter of 2013 in India